| Natera, Inc. Common Stock | $47.2b | $407.91 | 0.0% | 935 | |
| Illumina Inc | $32.2b | $273.95 | 0.0% | 1.1K | |
| Labcorp Holdings Inc. | $26.9b | $308.49 | +0.0% | 217 | |
| QIAGEN N.V. | $9.1b | $45.00 | +0.5% | 5.2K | |
| 10x Genomics, Inc. Class A Common Stock | $8.2b | $94.93 | 0.0% | 23.5K | |
| BillionToOne, Inc. Class A Common Stock | $4.5b | $105.75 | 0.0% | 220 | |
| Veracyte, Inc. | $3.6b | $46.02 | 0.0% | 341 | |
| GeneDx Holdings Corp. Class A Common Stock | $2.6b | $71.71 | 0.0% | 339 | |
| CareDx, Inc. | $2.6b | $67.19 | 0.0% | 547 | |
| NeoGenomics, Inc. | $2.2b | $18.46 | 0.0% | 1.4K | |
| Personalis, Inc. Common Stock | $1.8b | $16.14 | 0.0% | 4.0K | |
| Azenta, Inc. | $1.4b | $39.41 | 0.0% | 9.1K | |
| Opko Health Inc. | $1.2b | $1.55 | 0.0% | 3.1K | |
| Mesa Laboratories Inc | $0.7b | $132.13 | 0.0% | 736 | |
| Fulgent Genetics, Inc. Common Stock | $0.6b | $21.48 | 0.0% | N/A | |
| Prenetics Global Limited Class A Ordinary Share | $430.1m | $20.80 | 0.0% | 5.9K | |
| Pacific Biosciences of California, Inc. | $404.1m | $2.53 | 0.0% | 22.9K | |
| Myriad Genetics Inc | $308.9m | $4.50 | 0.0% | 1.9K | |
| Insight Molecular Diagnostics Inc. Common Stock | $131.2m | $3.52 | 0.0% | N/A | |
| Quantum Cyber N.V. Ordinary Shares | $127.8m | $1.34 | 0.0% | 27.1K | |
| ALPS Group Inc Ordinary Share | $63.2m | $0.39 | 0.0% | 67 | |
| Bionano Genomics, Inc. Common Stock | $15.0m | $1.49 | 0.0% | 2.6K | |
| BioNexus Gene Lab Corp Common stock | $4.3m | $1.18 | 0.0% | N/A |